4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-005215
VP and Chief Compliance Office gave up 1,186 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Herman James L VP and Chief Compliance Office | 2024-03-23 | Shares withheld for taxes | −1,186 | $1.81 | $2,147 | 38,255 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Herman James L VP and Chief Compliance Office | 2024-03-25 | Grant or award · Options (right to buy) | +4,000 | $1.71 | $6,840 | 16,000 | D: show line 2 in the form |
Loading xslF345X05/marketforms-65386.xml…